Stratos Wealth Advisors LLC Invests $216,000 in Healthpeak Properties, Inc. (NYSE:DOC)

Stratos Wealth Advisors LLC purchased a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 9,465 shares of the real estate investment trust’s stock, valued at approximately $216,000.

Other hedge funds also recently made changes to their positions in the company. Douglas Lane & Associates LLC bought a new position in shares of Healthpeak Properties in the third quarter valued at $33,947,000. Presima Securities ULC bought a new position in shares of Healthpeak Properties in the third quarter valued at $22,465,000. AMF Tjanstepension AB bought a new position in shares of Healthpeak Properties in the third quarter valued at $15,548,000. Handelsbanken Fonder AB bought a new position in shares of Healthpeak Properties in the third quarter valued at $11,668,000. Finally, Brookstone Capital Management bought a new position in shares of Healthpeak Properties in the third quarter valued at $11,018,000. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Stock Up 1.1 %

DOC opened at $22.43 on Wednesday. Healthpeak Properties, Inc. has a fifty-two week low of $15.24 and a fifty-two week high of $23.14. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.70 and a current ratio of 0.70. The company has a market capitalization of $15.79 billion, a P/E ratio of 64.09, a P/E/G ratio of 2.27 and a beta of 1.14. The stock has a fifty day moving average of $22.19 and a 200-day moving average of $20.60.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Thursday, July 25th. The real estate investment trust reported $0.21 earnings per share for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.23). Healthpeak Properties had a return on equity of 3.51% and a net margin of 11.93%. The firm had revenue of $695.50 million for the quarter, compared to analyst estimates of $665.11 million. During the same period in the prior year, the business posted $0.45 EPS. The firm’s quarterly revenue was up 27.5% compared to the same quarter last year. On average, equities analysts expect that Healthpeak Properties, Inc. will post 1.8 EPS for the current year.

Analysts Set New Price Targets

Several research firms recently weighed in on DOC. Evercore ISI raised their target price on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Monday, September 16th. Wedbush raised their target price on shares of Healthpeak Properties from $22.00 to $25.00 and gave the company an “outperform” rating in a research note on Monday, July 29th. Wells Fargo & Company reissued an “equal weight” rating and issued a $23.00 target price (up from $22.00) on shares of Healthpeak Properties in a research note on Tuesday, October 1st. Royal Bank of Canada raised their price target on Healthpeak Properties from $22.00 to $25.00 and gave the company an “outperform” rating in a report on Tuesday, July 30th. Finally, Deutsche Bank Aktiengesellschaft raised Healthpeak Properties from a “hold” rating to a “buy” rating and raised their price target for the company from $20.00 to $28.00 in a report on Monday. One analyst has rated the stock with a sell rating, five have given a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $22.62.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.